Vaneck Pharmaceutical ETF (PPH) closed at $121.71 on November 11, 2026, up 0.1% from the previous close, on volume of 235,029 shares (30-day average 396,108).
Data as of November 11, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 6, 2026 | 3 Leg Call Combo Calendar with Ratio | 18-Dec-26125 C|15-Jan-27103[2x] C|16-Apr-27103[2x] C | 300 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
No headlines found.
No press releases found.
No news found.
The Market Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.
Vaneck Pharmaceutical ETF trades on the NASDAQ stock market under the symbol PPH.
As of November 11, 2026, PPH stock price climbed to $121.71 with 235,029 million shares trading.
PPH has a beta of 0.02, meaning it tends to be less sensitive to market movements. PPH has a correlation of 0.00 to the broad based SPY ETF.
PPH has a market cap of $1.09 billion. This is considered a Small Cap stock.
In the last 3 years, PPH traded as high as $123.53 and as low as $75.50.
PPH has outperformed the market in the last year with a price return of +29.6% while the SPY ETF gained +12.6%. PPH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +8.3% and +6.2%, respectively, while the SPY returned -1.5% and -1.3%, respectively.
PPH support price is $119.66 and resistance is $123.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PPH shares will trade within this expected range on the day.
